Drug and disease signature integration identifies synergistic combinations in glioblastoma.
Stathias V, Jermakowicz AM, Maloof ME, Forlin M, Walters W, Suter RK, Durante MA, Williams SL, Harbour JW, Volmar CH, Lyons NJ, Wahlestedt C, Graham RM, Ivan ME, Komotar RJ, Sarkaria JN, Subramanian A, Golub TR, Schürer SC, Ayad NG.
Stathias V, et al. Among authors: ayad ng.
Nat Commun. 2018 Dec 14;9(1):5315. doi: 10.1038/s41467-018-07659-z.
Nat Commun. 2018.
PMID: 30552330
Free PMC article.